Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-09-30

Clinical Trial Update: Arginine Feeding: a Novel Strategy to Improve Protein Metabolism in Cancer and the Response to Surgery [NA]

View source ↗

Summary

A completed clinical trial sponsored by Texas A&M evaluated arginine feeding as a strategy to improve protein metabolism in cancer and influence recovery from s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Texas A&M University | Conditions: Protein Metabolism | NA | Status: COMPLETED